Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets:
Cash and cash equivalents	$ 23	$ 349
Other assets	0	61
Total assets	23	410
Liabilities:
Accounts payable and accrued liabilities	3,137	1,484
Loan(s) payable - related party	1,848	0
Total liabilities	4,985	1,484
Commitments and contingencies (Note 6)
Stockholders' equity (deficit):
Common stock ($0.01 par value, 85,000 authorized in 2023 and 85,000 authorized in 2022, 46,410 issued and 40,738 outstanding in 2023 and 46,410 issued and 40,738 outstanding in 2022)	464	464
Additional paid-in capital	548,304	548,304
Accumulated deficit	(548,562)	(544,674)
Treasury stock, at cost - 2023 - 5,672 shares; and 2022 - 5,672 shares	(5,168)	(5,168)
Total stockholders' equity (deficit)	(4,962)	(1,074)
Total liabilities and stockholders' equity (deficit)	$ 23	$ 410